eli lilly gip/glp-1 launches weight loss drug Mounjaro in India at Rs 3,500 per 2.5mg dose Novo Nordisk, Eli Lilly make

Effectiveness and Side Effects: Semaglutide appears to result in greater weight loss compared to liraglutide, but it is also associated with more frequent side effects

These data come from Cosmos, a dataset created in collaboration with a community of Epic health systems representing more than 300 million patient records from 1,900 hospitals and more than 42,000 clinics from all 50 U.S

This rise may relate to emerging evidence of its metabolic efficacy and weight loss benefits, which could be influencing prescribing patterns among patients with PCOS (16)

Survodutide is a dual GLP-1/glucagon receptor agonist showing promising results in clinical trials

Global DNA hypomethylation is associated with the development and poor prognosis of tongue squamous cell carcinoma